Suppr超能文献

甲状腺手术的最新进展。

An update on thyroid surgery.

作者信息

Gimm O, Brauckhoff M, Thanh P N, Sekulla C, Dralle H

机构信息

Universität- und Poliklinik für Allgemein-, Viszeral- und Gefässchirurgie, Ernst-Grube-Strasse 40, 06097 Halle, Germany.

出版信息

Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S447-52. doi: 10.1007/s00259-002-0913-3. Epub 2002 Jul 11.

Abstract

Surgery has been the treatment of choice for many disorders of the thyroid gland, both benign and malignant, for many decades. However, surgery has not been invariable but has continued to change in accordance with research results. In benign cases, surgery has generally evolved to be as organ preserving as possible. In several instances, however, a more radical extent of resection seems justified in order to ensure that the risk of recurrence is as low as possible. For instance, total thyroidectomy may be beneficial in patients with endemic multinodular goitre or young patients with Graves' disease and accompanying cold nodules or high levels of autoantibodies. Several tools, e.g. magnifying glasses, bipolar coagulation forceps and neuromonitoring, are available to identify and preserve the recurrent laryngeal nerve and the parathyroid glands, hence keeping the morbidity at a low level. Most recently, minimally invasive surgery has been successfully used in treating both benign and malignant disorders of the thyroid gland. In the case of malignant disorders, minimally invasive surgery may become an attractive alternative to open surgery if a limited surgical extent is justified, e.g. in patients with micro-PTC (papillary thyroid carcinoma, diameter less than 1 cm). Whether a limited surgical approach is also justified in other cases, e.g. in any patient with intrathyroidal PTC or patients with micro-FTC (follicular thyroid carcinoma), remains to be shown and is the subject of ongoing investigations. One of the most intriguing recent discoveries is the identification of genotype-phenotype correlations in patients with hereditary medullary thyroid carcinoma. In these patients, the timing and extent of surgery may depend not only on the patient's age and serum levels of the tumour marker calcitonin but also on the specific germline RET proto-oncogene mutation. Surgery will certainly continue to play an important role in the treatment of thyroid diseases and may be increasingly based on individual findings instead of general recommendations.

摘要

几十年来,手术一直是治疗甲状腺多种疾病(包括良性和恶性疾病)的首选方法。然而,手术并非一成不变,而是根据研究结果不断变化。在良性病例中,手术通常已发展为尽可能保留器官。然而,在某些情况下,为了确保复发风险尽可能低,更广泛的切除范围似乎是合理的。例如,对于地方性多结节性甲状腺肿患者或患有格雷夫斯病并伴有冷结节或自身抗体水平高的年轻患者,全甲状腺切除术可能有益。有几种工具,如放大镜、双极电凝钳和神经监测仪,可用于识别和保留喉返神经及甲状旁腺,从而将发病率保持在较低水平。最近,微创手术已成功用于治疗甲状腺的良性和恶性疾病。在恶性疾病的情况下,如果手术范围有限是合理的,例如对于微小乳头状甲状腺癌(直径小于1厘米)患者,微创手术可能成为开放手术的有吸引力的替代方法。在其他情况下,例如在任何甲状腺内乳头状甲状腺癌患者或微小滤泡状甲状腺癌患者中,有限的手术方法是否合理仍有待证明,并且是正在进行的研究的主题。最近最引人入胜的发现之一是在遗传性甲状腺髓样癌患者中发现了基因型与表型的相关性。在这些患者中,手术的时机和范围不仅可能取决于患者的年龄和肿瘤标志物降钙素的血清水平,还可能取决于特定的种系RET原癌基因突变。手术肯定会继续在甲状腺疾病的治疗中发挥重要作用,并且可能越来越多地基于个体发现而不是一般建议。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验